Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular alterations in non-small cell lung carcinomas of the young.

Human pathology - 1 Dec 2014

VandenBussche Christopher J, Illei Peter B, Lin Ming-Tseh, Ettinger David S, Maleki Zahra

Abstract excerpt

Lung cancer is the leading cause of cancer death in the United States. Gene alterations are significant in lung tumorigenesis, with certain genes (Kristen rat sarcoma viral oncogene homolog (KRAS), epidermal growth factor receptor [EGFR], anaplastic lymphoma kinase [ALK], and B-Raf proto-oncogene, serine/threonine kinase (BRAF)) possessing alterations important in the prognosis and treatment of lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mutational Analysis
Share to ErbB Receptors
Share to EGFR gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Gene Rearrangement

Share to Lung Neoplasms

Share to Mutation

Share to Proto-Oncogene Proteins

Source

Identifiers

PMID: 25288236
DOI: 10.1016/j.humpath.2014.08.005

Genes

KRAS
ALK
EGFR
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular alterations in non-small cell lung carcinomas of the young.PMID 25288236Read ↗

Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger.Semantic proximity Read ↗

EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancerSemantic proximity Read ↗

Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.Semantic proximity Read ↗

Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.Semantic proximity Read ↗

Genetic and Biochemical Alterations in Non-Small Cell Lung CancerSemantic proximity Read ↗

Rare mutations in non-small-cell lung cancer.Semantic proximity Read ↗

Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder.Semantic proximity Read ↗

Somatic mutations of signaling genes in non-small-cell lung cancer.Semantic proximity Read ↗

Molecular pathology of non-small-cell lung cancer.Semantic proximity Read ↗

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.Semantic proximity Read ↗

Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status.Semantic proximity Read ↗

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.